VR Logo

Alembic Pharmaceuticals Ltd. download report


Healthcare | Drugs & Pharma

Alembic Pharmaceuticals Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Alembic Pharmaceuticals Ltd. Annual Report
2020 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2019 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2018 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2017 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2016 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2015 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2014 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2013 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2012 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes
2011 Alembic Pharmaceuticals Ltd. Annual Report Alembic Pharmaceuticals Ltd. chairman speech Alembic Pharmaceuticals Ltd. director's report Alembic Pharmaceuticals Ltd. management discussion Alembic Pharmaceuticals Ltd. corporate governance Alembic Pharmaceuticals Ltd. auditor's report Alembic Pharmaceuticals Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2010

Chairman: Chirayu Amin

Managing Director: Shaunak Amin

Group: Alembic

Listing: BSE: 533573, NSE: APLLTD

Country: India

Headquarters: Vadodara, Gujarat

Website: www.alembicpharmaceuticals.com

Key Facts

Market cap: ₹14,511.27 Cr

Revenue (TTM): ₹5,305.79 Cr

Earnings (TTM): ₹545.70 Cr

Cash: ₹69.43 Cr

Total Debt: ₹499.79 Cr

Promoters' ownership: 69.61%

Liquidity: High

52 Week range: ₹678.30 - 1,016.70

Face value: ₹2.00

Shares outstanding: 19,65,63,124

10 Years Aggregate:

  • CFO: ₹5,131.44 Cr
  • EBITDA: ₹7,001.78 Cr
  • Net Profit: ₹4,869.58 Cr

Stock Performance

Time Period Alembic Pharmaceuticals S&P BSE Healthcare S&P BSE Mid Cap
YTD-7.67-17.46-12.65
1 month0.91-3.75-3.14
3 months-2.78-10.67-7.95
1 Year-26.08-14.72-3.66
3 Years13.3218.8313.78
5 Years7.959.098.50
10 Years29.7912.3413.67
As on 29-Jun-2022
Year Alembic Pharmaceuticals S&P BSE Mid Cap S&P BSE Healthcare
2021-23.0939.1820.87
202087.7219.8761.45
2019-2.65-3.05-3.55
201812.90-13.31-5.89
2017-10.8448.130.49
2016-13.487.97-12.88
201556.357.4315.06